Does APIXABAN Cause Coagulopathy? 271 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 271 reports of Coagulopathy have been filed in association with APIXABAN (ELIQUIS). This represents 0.2% of all adverse event reports for APIXABAN.
271
Reports of Coagulopathy with APIXABAN
0.2%
of all APIXABAN reports
46
Deaths
122
Hospitalizations
How Dangerous Is Coagulopathy From APIXABAN?
Of the 271 reports, 46 (17.0%) resulted in death, 122 (45.0%) required hospitalization, and 35 (12.9%) were considered life-threatening.
Is Coagulopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 271 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Coagulopathy?
RIVAROXABAN (1,002)
ACETAMINOPHEN (977)
DABIGATRAN ETEXILATE (718)
ASPIRIN (674)
WARFARIN (589)
METHOTREXATE (414)
VINCRISTINE (275)
CYCLOPHOSPHAMIDE (240)
PREDNISONE (228)
IBUPROFEN (227)
Which APIXABAN Alternatives Have Lower Coagulopathy Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ